IN

InnovAge Holding Corp.

INNVHealthcareNASDAQ

Medical Care Facilities · Last scanned Oct 26, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$989.7M
+15.9% YoY
Net Income
-$2.5M
+91.6% YoY
EBITDA
$25.7M
+359.1% YoY
Free Cash Flow
$49.5M

Scan Results

Daily timeframe
3 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Oct 20▼ Below MA2000.1% below MA200
Oct 19▼ Below MA2000.2% below MA200
About InnovAge Holding Corp.

InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors. The $1.30B market capitalization puts INNV squarely in small-cap range for its industry. It manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach.

Where INNV stands vs its 150-day and 200-day moving averages

As of the October 20, 2026 close, INNV finished 5.63% below its 150-day moving average ($9.41) and 0.11% below its 200-day moving average ($8.89). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is INNV overbought or oversold?

At the October 20, 2026 close, INNV's RSI(14) was 45.2, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$1.30B
Fwd P/E19.10
EPS$-0.02
Beta0.15
52W Change+90.2%
Dividend Yield0.00%
ROE-0.3%
Analysis

InnovAge Holding Corp. holds $141.3M in cash against $87.0M in total debt, giving it a net cash position. This means the company could theoretically pay off all its debt and still have cash remaining. Free cash flow comes in at $49.5M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROE of -0.3% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 0.7% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $688.1M (2023) to $989.7M (2026), reflecting a 44% increase over the period.

INNV's low beta indicates it tends to be less volatile than the broader market, which may suit investors seeking more stable price behavior. No single metric tells the full story. Reviewing INNV's risk profile alongside its fundamentals and technical indicators provides a more complete picture.

Links
More Healthcare stocks
Browse all stocks →
⚠Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms